Sponsored Content

Migraine: More Than Just a Headache

This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.

 

Read Now

Though a common neurologic disease with substantial impact, migraine is underdiagnosed and undertreated. 1,2 The American Migraine Prevalence and Prevention study of 18,968 people found that approximately 44% of subjects who met the International Classification of Headache Disorders 2nd edition (ICHD-2) criteria for migraine had never received a medical diagnosis of
migraine.
2

This sponsored content discusses the pathophysiology, characteristic symptoms, and burden of migraine, as well as how to help facilitate the diagnosis of migraine in the primary care setting.

This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.

Reference:

1 GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Lancet. 2018;392(10159): 1789-1858.

2 Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Headache. 2007;47(3):355-363.

USA-334-83661

Read Now

Recommended Reading

Today's top news highlights
MDedge Internal Medicine
Lessons learned during the COVID-19 pandemic
MDedge Internal Medicine
COVID-19 triggers new bariatric/metabolic surgery guidance
MDedge Internal Medicine
Glucose control linked to COVID-19 outcomes in largest-yet study
MDedge Internal Medicine
Planning for a psychiatric COVID-19–positive unit
MDedge Internal Medicine
Proteins in urine may predict active lupus nephritis
MDedge Internal Medicine
Dermatologic changes with COVID-19: What we know and don’t know
MDedge Internal Medicine
Frontal lobe glucose abnormalities may indicate increased SUDEP risk
MDedge Internal Medicine
Time to change WHO definition of osteoporosis, say experts
MDedge Internal Medicine
COVID-19 in kids: Severe illness most common in infants, teens
MDedge Internal Medicine